EFM
CYTK icon

E Fund Management’s Cytokinetics CYTK Stock Holding History

E Fund Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$522K Sell
6,123
-3,027
-33% -$217K 0.01% 257
2026
Q1 		$603K Buy
+9,150
New +$582K 0.02% 246
2025
Q2 		$625K Buy
18,919
+5,136
+37% +$179K 0.03% 204
2025
Q1 		$554K Buy
13,783
+2,039
+17% +$93.7K 0.03% 213
2024
Q4 		$552K Sell
11,744
-1,993
-15% -$104K 0.03% 214
2024
Q3 		$725K Sell
13,737
-2,190
-14% -$122K 0.04% 166
2024
Q2 		$863K Buy
15,927
+9,336
+142% +$564K 0.05% 137
2024
Q1 		$462K Sell
6,591
-7,494
-53% -$580K 0.03% 166
2023
Q4 		$1.18M Buy
14,085
+1,404
+11% +$50.8K 0.07% 81
2023
Q3 		$374K Buy
12,681
+619
+5% +$20.6K 0.03% 177
2023
Q2 		$393K Buy
12,062
+1,214
+11% +$44.9K 0.03% 176
2023
Q1 		$382K Sell
10,848
-958
-8% -$39.1K 0.03% 181
2022
Q4 		$541K Buy
11,806
+3,068
+35% +$132K 0.05% 123
2022
Q3 		$423K Sell
8,738
-2,348
-21% -$113K 0.04% 167
2022
Q2 		$436K Buy
11,086
+3,932
+55% +$158K 0.04% 172
2022
Q1 		$263K Buy
7,154
+2,350
+49% +$83.5K 0.01% 243
2021
Q4 		$219K Sell
4,804
-1,036
-18% -$40K 0.01% 244
2021
Q3 		$209K Buy
+5,840
New +$172K 0.01% 227

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

E Fund Management's CYTK Position: Q2 2026 in Review

E Fund Management reduced its Cytokinetics (CYTK) stake by 33% in Q2 2026, selling an estimated $217K and leaving 6,123 shares worth $522K. The position accounts for 0.01% of the portfolio, ranked #257.

E Fund Management first reported a position in CYTK in Q3 2021 and has held it in 18 quarters since. The position peaked at $1.18M in Q4 2023. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • E Fund Management held 6,123 shares of Cytokinetics worth $522K as of Q2 2026.
  • E Fund Management sold 3,027 Cytokinetics shares in Q2 2026, an estimated $217K.
  • Cytokinetics made up 0.01% of E Fund Management's portfolio in Q2 2026, its #257 holding.
  • E Fund Management first reported a position in Cytokinetics in Q3 2021 and has held it in 18 quarters since.
  • E Fund Management's Cytokinetics position peaked at $1.18M in Q4 2023.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.